About file location

As the EGA is co-managed by the EMBL-EBI and CRG, files could be located in the UK and/or Spain, as indicated by their respective flags.

Alternatively, files could be located in one of the international Federated EGA nodes, as indicated next to the node's flag.
Need Help?

ChIP-Seq (Input) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, as part of the International Human Epigenome Consortium.

ChIP-Seq (Input) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.

Request Access

DUO:0000012
version: 2021-02-23

research specific restrictions

This data use modifier indicates that use is limited to studies of a certain research type.

DUO:0000025
version: 2021-02-23

time limit on use

This data use modifier indicates that use is approved for a specific number of months.

DUO:0000026
version: 2021-02-23

user specific restriction

This data use modifier indicates that use is limited to use by approved users.

DUO:0000027
version: 2021-02-23

project specific restriction

This data use modifier indicates that use is limited to use within an approved project.

BC Cancer, part of the Provincial Health Services Authority - Data Access Policy

Access to this data is controlled. There are a number of steps that a researcher must take to obtain access to this data, including execution of a Data Access Agreement between the institutions. The process is overseen by the Technology Development Office; please contact our general email address TDOadmin@phsa.ca. Please only click the "request data" button on the EGA website after a Data Access Agreement is fully executed.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001000552 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
i
EGAF00000586051 bam 5.5 GB Report
EGAF00000586058 bam 12.4 GB Report
EGAF00000586065 bam 4.6 GB Report
EGAF00000586072 bam 4.8 GB Report
EGAF00000586079 bam 5.7 GB Report
EGAF00000586086 bam 4.1 GB Report
EGAF00000586093 bam 9.7 GB Report
EGAF00000586100 bam 8.7 GB Report
EGAF00000586107 bam 7.1 GB Report
EGAF00000586114 bam 7.8 GB Report
EGAF00000733022 bam 8.7 GB Report
EGAF00000733051 bam 5.6 GB Report
EGAF00000733057 bam 4.1 GB Report
EGAF00000733060 bam 4.6 GB Report
EGAF00000733067 bam 5.0 GB Report
EGAF00000765041 bam 4.3 GB Report
EGAF00000765042 bam 4.6 GB Report
EGAF00000835470 bam 7.8 GB Report
EGAF00000835483 bam 9.9 GB Report
EGAF00000835496 bam 9.8 GB Report
EGAF00000864340 bam 8.1 GB Report
EGAF00000864348 bam 5.2 GB Report
EGAF00000864351 bam 5.3 GB Report
EGAF00000864363 bam 4.1 GB Report
EGAF00000864376 bam 4.5 GB Report
EGAF00000864377 bam 5.7 GB Report
EGAF00000864384 bam 5.0 GB Report
EGAF00000864393 bam 3.8 GB Report
EGAF00000864398 bam 6.6 GB Report
EGAF00000864402 bam 5.0 GB Report
EGAF00000887880 bam 10.8 GB Report
EGAF00000887888 bam 10.5 GB Report
EGAF00000887896 bam 11.2 GB Report
EGAF00000887900 bam 7.2 GB Report
EGAF00000887911 bam 5.5 GB Report
EGAF00000887926 bam 10.2 GB Report
EGAF00000887929 bam 5.9 GB Report
EGAF00000887935 bam 10.3 GB Report
EGAF00000887938 bam 8.4 GB Report
EGAF00000887947 bam 9.7 GB Report
EGAF00000887961 bam 8.9 GB Report
EGAF00000887967 bam 9.3 GB Report
EGAF00000887977 bam 8.9 GB Report
EGAF00000887981 bam 9.4 GB Report
EGAF00000887986 bam 12.3 GB Report
EGAF00000887991 bam 10.6 GB Report
EGAF00000887995 bam 11.4 GB Report
EGAF00000888672 bam 6.3 GB Report
48 Files (355.0 GB)